We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
-1.73%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
10 Year Est. Return
AUM
$53.9M
AUM Growth
-$5.16M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWL icon
1
American Well
AMWL
$180M
$27.2M 50.52%
315,039
ANNX icon
2
Annexon
ANNX
$834M
$7.37M 13.68%
1,954,978
ASMB icon
3
Assembly Biosciences
ASMB
$498M
$4.68M 8.68%
185,625
WHWK
4
Whitehawk Therapeutics
WHWK
$190M
$4.62M 8.57%
374,785
RNTX
5
Rein Therapeutics
RNTX
$63.1M
$4.32M 8.01%
830,472
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.03M 7.49%
126,270
AKBA icon
7
Akebia Therapeutics
AKBA
$354M
$1.64M 3.05%
4,652,561

Similar funds

Alerce Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Alerce Investment Management held 7 positions worth $53.9M, down 8.7% from $59M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Alerce Investment Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management's ten largest holdings make up 100% of its $53.9M portfolio in Q2 2022.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q2 2022.
  • Alerce Investment Management's portfolio value fell 8.7% quarter-over-quarter to $53.9M.

Based on Alerce Investment Management's 13F filing for Q2 2022, filed 4 Aug 2022.